Psoriasis is a common skin disease that affects about 2% of the US population. The most common form is plaque-type. Ixekizumab is FDA-indicated for the adult treatment of moderate to severe plaque psoriasis. These adult patients are also candidates for systemic therapy or phototherapy. Safety and effectiveness have been determined in pediatric patients. Psoriasis will be briefly discussed to become familiar with ixekizumab’s mechanism of action and its therapeutic use. This activity highlights the role of the interprofessional team in managing patients prescribed ixekizumab for psoriasis.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/37215
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABOS - 1.0 Point; Credit Type(s): Accredited CME (ABOS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Adult Reconstruction, Ambulatory/Outpatient, Chemical Pathology, Dermatopathology, Foot and Ankle, General Operative Anesthesia, General Orthopaedics, General Pediatrics, General Surgery, Internal Medicine, Orthopaedic Sports Medicine, Pediatric Orthopaedic Surgery, Pediatric Rheumatology, Rheumatology, Shoulder and Elbow, Soft Tissue & Bone, Surgery of the Hand, Surgery of the Spine
Subscribe
Login
0 Comments
Oldest